DOI: 10.32098/mltj.04.2020.02

Randomized Trial of Hymovis® versus Synvisc® on Matrix Metalloproteinases in Knee Osteoarthritis

Authors

  • E. Falcinelli Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy
  • N. Giordan Clinical Research Department, Fidia Farmaceutici SpA, Abano Terme, Italy
  • F. Luccioli Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy
  • E. Piselli Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy
  • G. M. C. La Paglia Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy
  • S. Momi Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy
  • G. Mirabelli Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy
  • E. Petito Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy
  • A. Alunno Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy
  • P. Gresele Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy
  • R. Gerli Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy

emanuela.falcinelli@outlook.it

Keywords

Hyaluronic acid, knee, metalloproteinases, osteoarthritis, sodium hyaluronate, cytokines

Abstract

Background. This study aims to evaluate the effects of HYADD 4-G, a not chemically cross-linked HA (Hyaluronic Acid) derivative, and hylan G-F 20, a cross-linked HA product, on synovial matrix metalloproteinases and cytokines in patients suffering from knee osteoarthritis.

Methods. 31 patients were randomized to receive HYADD 4-G or hylan G-F 20. Synovial fluid was collected before and one week after the first injection. Activity of MMP-3, MMP-2, MMP-13, IL-6 and other cytokines were measured. Changes in synovial fluid neutrophils and lymphocytes were analyzed. The VAS, the WOMAC questionnaire, and a Physician Global Assessment (PhGA VAS) were recorded.

Results. A trend towards a greater decrease in MMP-3 activity was observed in the Hymovis® group. Active MMP-2 and MMP-13 decreased in both groups. IL-6 levels also decreased significantly in both groups. Median change in neutrophils from baseline was significantly different between the treatment groups. No differences between the treatment groups were observed for the WOMAC, VAS and PhGA VAS scores. No serious adverse events were reported.

Conclusions. These findings demonstrate that intra-articular HA injections in patients with knee osteoarthritis tend to protect cartilage structural integrity reducing the activity of key proteolytic enzymes implicated in cartilage degradation as well as inflammatory mediators.

View the entire article

Downloads

Published

2020-12-31

How to Cite

1.
Falcinelli E, Giordan N, Luccioli F, Piselli E, La Paglia GMC, Momi S, et al. Randomized Trial of Hymovis® versus Synvisc® on Matrix Metalloproteinases in Knee Osteoarthritis. MLTJ [Internet]. 2020 Dec. 31 [cited 2026 Nov. 20];10(4). Available from: https://mltj.online/index.php/mltj/article/view/6982

Most read articles by the same author(s)